Service Navigation

REGIS-TR adds Control Now to its partnership programme

Release date: 26 Apr 2021 | Clearstream

REGIS-TR adds Control Now to its partnership programme


REGIS-TR is teaming up with Control Now, a provider of automated, multi-regulation post trade reconciliation and compliance tools, in connection with their partnership programme. Reflecting their collaboration, the official partnership is aiming at empowering market participants to meet their reporting obligations in major European regulations.

Nick Bruce, Head of Business Development for REGIS-TR, commented: “We are delighted to welcome Control Now to our expanding partnership programme. The innovative software company is a fantastic addition, sharing our common goal of delivering fresh, client-centric solutions to ease the burden of meeting reporting obligations.”

Murray Abel, Managing Director of Control Now Ltd, said: “Control Now continues to support its clients to mitigate compliance risk with its automated post reporting assurance tools. As a regulatory technology company, we are delighted and honoured to partner with REGIS-TR and share its vision to simplify regulatory reporting obligations from a post reporting viewpoint.”

REGIS-TR continues to expand its partnership programme with many of the leading brands in the regulatory reporting space. The wide range of partners from industry leading organisations allows REGIS-TR’s clients to benefit from operational advantages and greater levels of efficiency.

About REGIS-TR

REGIS-TR is the leading European trade repository offering reporting services covering all the major European trade repository obligations. In accordance with legislation promoting market transparency, the detail of the trades reported is aggregated to present a composite view of current positions for the benefit of regulatory authorities and market participants. REGIS-TR is open to financial and non-financial companies and institutions.

REGIS-TR is a joint venture of Clearstream (Deutsche Börse Group) and Iberclear (BME Group).

Further information